Insider Shareholders with Direct Ownership of Zynerba Pharmaceuticals, Inc. (ZYNE)
This section provides a comprehensive overview of the insiders with direct ownership of Zynerba Pharmaceuticals, Inc. (ZYNE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Zynerba Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armando Anido
Chairman & Chief Exec. Officer |
913,665 | 1,266,177 | 936,722 $0 | 14 |
Sep 13, 2023
Reduced 1.87%
|
|
Suzanne M. Hanlon
Sec, VP & General Counsel |
37,000 | 0 | 80,693 $0 | 1 |
Jan 21, 2021
Added 31.44%
|
|
James E Fickenscher
Chief Financial Officer |
572,620 | 593,338 | 0 $0 | 14 |
Oct 10, 2023
Reduced 100.0%
|
|
Brian Rosenberger
VP, Commercial & Business Dev. |
402,876 | 402,876 | 0 $0 | 14 |
Oct 10, 2023
Reduced 100.0%
|
|
Terri B Sebree
President |
644,732 | 830,878 | 0 $0 | 14 |
Oct 10, 2023
Reduced 100.0%
|
| 75,933 | 75,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
| 75,933 | 75,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
|
Albert P Parker
Chief Legal Officer |
326,495 | 326,495 | 0 $0 | 9 |
Oct 10, 2023
Reduced 100.0%
|
| 75,933 | 80,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
| 75,933 | 75,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
| 75,933 | 75,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
| 75,933 | 75,933 | 0 $0 | 6 |
Oct 10, 2023
Reduced 100.0%
|
|
| 39,000 | 118,025 | 0 $0 | 4 |
Oct 10, 2023
Reduced 100.0%
|